Myriam Curet McAdams - 27 Feb 2026 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet
Issuer symbol
ISRG
Transactions as of
27 Feb 2026
Net transactions value
-$3,514,148
Form type
4
Filing time
02 Mar 2026, 15:41:09 UTC
Previous filing
27 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curet Myriam EVP & Chief Medical Officer 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet 02 Mar 2026 0001632901

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Sale $1,171,820 -2,345 -85% $499.71 409 27 Feb 2026 by Trust F1
transaction ISRG Common Stock Options Exercise $0 +1,002 +245% $0.000000 1,411 28 Feb 2026 by Trust F2
transaction ISRG Common Stock Tax liability $250,244 -497 -35% $503.51 914 28 Feb 2026 by Trust F2
transaction ISRG Common Stock Options Exercise $0 +8,378 +917% $0.000000 9,292 28 Feb 2026 by Trust F3
transaction ISRG Common Stock Tax liability $2,092,084 -4,155 -45% $503.51 5,137 28 Feb 2026 by Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Performance Stock Units - 2-28-2023 Options Exercise $0 -8,378 -100% $0.000000 0 28 Feb 2026 Common Stock 8,378 $0.000000 Direct F3
transaction ISRG Restricted Stock Units Options Exercise $0 -1,002 -100% $0.000000 0 28 Feb 2026 Common Stock 1,002 $0.000000 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
F2 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F3 Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
F4 This transaction represents the withholding of shares to cover taxes applicable to a settlement of PSUs reported on this Form 4.
F5 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.